The authors examined the usefulness of nested PCR (N-PCR) to detect Mycobacterium tuberculosis (MTB) DNA in CSF for assessing the clinical course of tuberculous meningitis (TBM). N-PCR successfully detected MTB DNA in all nine CSF samples from patients with suspected TBM. During anti-tuberculosis treatments, N-PCR results converted from positive to negative, correlating with the improvement of the patient's clinical condition.
Methods. Nine serial patients with suspected TBM and 20 non-TBM control patients were selected among patients who were admitted to our hospital between July 2000 and April 2004. All nine suspected TBM patients met the established clinical criteria and supporting evidence for TBM 1, 6, 9, 10 (table 1) , and were classified as two confirmed cases (positive CSF culture or AFB smear) and seven highly probable cases (meeting all the clinical criteria and with all three supporting evidences positive, but having no bacterial isolation). 6, 9 A total of 36 CSF samples from these nine patients were collected. Of 36 samples, 27 were available from the seven highly probable patients who had follow-ups of more than at least 2 weeks. The non-TBM control group consisted of four cases of bacterial meningitis, three cryptococcal meningitis, three viral meningitis, six multiple sclerosis, and one each CNS lupus, CNS malignant lymphoma, hepatic insufficiency, and neuro Behçet disease. The diagnoses for the non-TBM control cases were based on their specific clinical and laboratory findings.
For DNA extraction and purification, the phenol-chloroform method and ethanol precipitation were used. For the two subsequent amplification steps of N-PCR, two pairs of oligonucleotide primers capable of specifically amplifying the MPB64 gene 5,6 of MTB were prepared. The outer primers used in the first step PCR (S-PCR) were F-1: 5'-ATCCGCTGCCAGTCGTCTTCC-3' and R-1: 5'-CTCGCGAGTCTAGGCCAGCAT-3'. The inner primers used in the second step PCR (N-PCR) were F-2: 5'-CATTGTGCAA-GGTGAACTGAGC-3' and R-2: 5'-AGCATCGAGTCGATCGCG-GAA-3'. As the template, 2 L of the extracted DNA specimen at the first step or 2 L of the S-PCR product at the second step was added to the PCR reaction-solution mixture (total reaction volume 20 L). These preparations were subjected to the previous reported protocol. 6 The S-and N-PCR products were analyzed by an automatic electrophoresis system. The presence of a 239 base-pair (bp) band for S-PCR and a 194 bp band for N-PCR indicated successful amplification.
For PCR amplification markers, we prepared original plasmids that were inserted a DNA fragment (239 bp) of the MPB64 gene. The nucleotide sequence of the inserted DNA fragment was confirmed by direct sequencing in both strands. Concentrations of the plasmid DNA were measured by a UV spectrophotometer at least three times, and then eight serial preparations of 10-fold dilutions were prepared (1 to 10 7 copies/2 L). To examine the minimum detection sensitivity of N-PCR, we constructed imitative CSF samples containing each of these plasmid preparations (1 to 10 7 copies). Using the same procedure carried out for the actual CSF analysis, we then performed extraction and purification of the DNA from these imitative samples.
Results. Table 1 summarizes the clinical features upon admission (before the anti-tuberculosis treatment [ATT]) and the outcomes in the nine suspected TBM patients. Conventional S-PCR only revealed positive results in 2 (22.2%) out of the nine patients and these cases were the confirmed (culture positive) cases (Cases 1 and 2) (figure, A). N-PCR results were positive in all 9 patients (100%) (figure, B). The 20 patients in the non-TBM control group had all negative N-PCR results (data not shown).
The results of the minimum detection sensitivity study for the S-and N-PCR are shown in the figure. When using the same experimental conditions as that for the actual CSF samples, the detection limit for the conventional S-PCR was only to 10 4 copies/2 L extracted plasmid from imitative CSF sample (figure, C). In contrast, the limit for the N-PCR was 1 to 10 copies/2 L extracted plasmid (figure, D). Table 2 summarizes the results of the diachronic study, which includes cultures for MTB, the S-and N-PCRs, and A ϭ The clinical criteria suggestive for TBM are fever, headache, and neck stiffness of more than 1 week duration.
B ϭ Supporting evidence for TBM include 1) compatible abnormal CSF findings that included increased white cell counts with lymphocyte predominating, hypoglycorrhachia, protein concentration Ͼ 100 mg/dL, adenosine deaminase (ADA м 10 IU/L and negative results for routine bacterial and fungal cultures; 2) MRI findings suggesting tuberculous involvement of the CNS (basal exudates, hydrocephalus, and intracranial focal mass, etc.); 3) presence of tuberculosis in the body outside of the CNS or a history of tuberculosis; and 4) clinical response to anti-tuberculosis therapy.
The suspected TBM cases were classified as "confirmed" cases (having the bacterial isolation for MTB such as CSF culture or AFB smear positive) or "highly probable" cases (meeting all the above clinical criteria and with all three supporting evidence positive). Discussion. Although several investigators have discussed the minimum detection sensitivity of N-PCR for MTB DNA, [6] [7] [8] [9] there have been no studies that have reported actual copy numbers for the purified MTB DNA. Using the original plasmid preparations, we established the minimum detection sensitivity of N-PCR to be between 1 and 10 copies/2 L, which was 1,000 to 10,000 times higher than that for S-PCR.
At present, although the gold standard in diagnosis of TBM is bacterial isolation, that still has sev- eral complex issues. In the present study, both conventional cultures and S-PCRs were positive in only 2 out of 9 patients (22.2%). These results suggest that when the amount of MTB in the CSF from suspected TBM patients is low, it may be difficult to demonstrate MTB presence by using conventional methods. In the present diachronic study, only N-PCR results revealed significant alterations during the clinical course for all seven highly probable patients. To our knowledge, there has only been one other previous diachronic study in which serial N-PCR was performed to examine CSF samples collected during the clinical treatment course from 12 patients with AIDS with suspected TBM. 9 We speculated that the diachronic alterations of the N-PCR results might reflect the clinical ATT response more sensitively than conventional methods. However, the assessment of the clinical course of TBM is difficult, since TBM has many complications, such as hydrocephalus and vasculopathy, which are really not dependent upon the presence of bacterial protein or DNA in the CNS but rather on the immunologic reaction of the host. Consequently, N-PCR is a much more sensitive, specific, and useful method as compared to other conventional methods such as MTB cultures and S-PCR. To establish the usefulness and superiority of N-PCR, both for TBM diagnosis and in the assessment of the clinical course of TBM against other conventional methods, it will be necessary to accumulate and evaluate a larger number of patients with suspected TBM. plasmid; lane 9: 1 copy/2 L plasmid. The detection limit for conventional S-PCR was to 10 4 copies/2 L extracted plasmid (C). The detection limit for N-PCR was 1 to 10 copies/2 L extracted plasmid (D).
